Publications by authors named "Nadia Heramvand"
Article Synopsis
- A study examined the relationship between serum phosphate levels and patient outcomes in cardiac arrest (CA) victims who achieved return of spontaneous circulation (ROSC).
- Elevated phosphate levels (greater than 2.7 mmol/L) were found to significantly predict higher mortality rates and impaired neurological function in CA patients upon discharge.
- The research included analysis of data from both a German hospital and a larger multi-centric cohort, finding consistent results that suggest phosphate level testing may enhance prognostic accuracy after CPR.
Aims: Patients with acute coronary syndrome (ACS) frequently suffer from anaemia, but its role in patients admitted to an intensive care unit (ICU) is unclear. This analysis evaluates the prognostic relevance of different degrees of anaemia and their specific impact on disease severity and the outcome in critically ill ACS patients.
Methods And Results: and results The multi-centre electronic Intensive Care Unit Collaborative Research Database was used, and all patients admitted with ACS were included in a retrospective analysis.
Tirofiban is a glycoproteine (GP) IIb/IIIa receptor antagonist, which inhibits platelet-platelet aggregation and is a potential adjunctive antithrombotic treatment in patients with acute coronary syndromes (ACS) or high-risk percutaneous coronary interventions (PCI). It is administered intravenously as a bolus followed by continuous infusion. However, the dosage recommendations in the United States (US) and European Union (EU) differ considerably.
View Article and Find Full Text PDFRationale And Objectives: Acidosis and hyperlactatemia predict outcome in critically ill patients. We assessed BE and pH for risk prediction capabilities in a sub-group of septic patients in the MIMIC-III database.
Methods: Associations with mortality were assessed by logistic regression analysis in 5586 septic patients.
Background: Cangrelor is an intravenous adenosine diphosphate (ADP) P2Y12 receptor antagonist, which has to be administered as a bolus followed by immediate infusion. Nevertheless, in clinical routine deviations from the correct practice, such as delayed infusion onset or interruptions during infusion, may occur.
Objective: The objective of the present study was to investigate the impact of administration delays on cangrelor concentration in a pharmacological simulation setting and to give possible solutions for the clinical practice.